Bright Health is yesterday's top mover after declining 42.05%
Leading equity indices in the US declined as Nasdaq shed 0.66% and closed at 11,379. S&P 500 was down 0.47% before closing the session at 3,951.39.
Today's price action is taking place amid mixed market indicators – United States Crude Oil Inventories released yesterday at 15:30 UTC is better than expected at 1.17 million but down from preceding data of 7.65 million according to new data.
“Top Movers” are assets that recorded the highest percentage change compared to their nearest peers. yesterday's most active stocks are listed below.
Bright Mountain Media posts solid session with 50% gain; upside capped at 15 cents
Bright Mountain Media, Inc. leaps up 50% to close at 15 cents yesterday. The company has a market cap of $22.37 million with an average daily volume of 7,238 shares.
Bright Health ended the session at 50.42 cents (-42.05%)
Early in yesterday's session, Bright Health dropped to 50.42 cents from 87 cents at the end of Tuesday, before closing at 50.42 cents. During the session, it lost 42.05%. Bright Health's market cap is currently $317.69 million with an average daily trading volume of 1.15 million shares. So far this year, it has been under-performing the Nasdaq by 15.15%.
Bearish mood pushes FIGS to session low of $6.7
Yesterday's session continued down the same path: after ending Tuesday at $9.21, FIGS dropped to $6.7 early in yesterday's session and closed at $6.76. In total, it lost 26.6%. The company's market cap currently stands at $1.12 billion with an average daily trading volume of 4.48 million shares.
FIGS was down, even though its quarterly earnings released on Tuesday beat the analysts’ estimates. The reported earnings of 0.05 per share on revenue of $144.90 million, topping estimates of 0.01 per share on revenue of $134.16 million.
Risk-off mood drags Novavax 25.92% lower
After ending Tuesday at $9.26, Novavax declined to $6.64 yesterday before closing at $6.86, thereby losing 25.92% in total. The US vaccine developer's market cap currently stands at $583.13 million with an average daily trading volume of 6.51 million shares. So far this year, it has been doing worse than the Nasdaq by 32.7%.
The company reported earnings of -2.28 per share Tuesday, falling short of expectations of -0.92. Revenue was also lower than expected at $357.40 million versus $383.14 million. Novavax lost 20.88% since the release of its earnings report.